« Return to News | CROs/Service Providers

The Hamner Institutes for Health Sciences partners with QPS Holdings

Wednesday, February 20, 2013 10:26 AM

The Hamner Institutes for Health Sciences, a nonprofit research organization focused on translational safety sciences, and QPS Holdings, a Newark, Delaware-based CRO, have announced the launch of QPS Hepatic Biosciences, a center of excellence for cell based research and services. 

Hepatic Biosciences is a new division within the QPS DMPK department and will specialize in hepatocyte research, drug metabolism, drug transporter sciences and in vitro drug-drug interactions. The scientific discipline of this new operation at The Hamner Institutes is jointly led by Drs. Edward LeCluyse, associate investigator at The Hamner, and Caroline Lee, director of drug metabolism and transporter sciences at QPS. 

Hepatic Biosciences has also assumed responsibility for all GLP-compliant quality assurance and bioanalysis in support of The Hamner. In addition to augmenting existing Hamner research programs, QPS will focus on new business development for both organizations.

"Strengthening in vitro ADME within QPS is a logical extension of our bench-to-the-bedside strategy in bridging preclinical data to phase I by addressing drug-drug interaction concerns,” said Benjamin Chien, PhD, chairman, president and CEO of QPS Holdings. “The collaboration with The Hamner reinforces the QPS philosophy of providing outstanding science and services to our customers.  QPS is very pleased to collaborate with the many distinguished scientists within The Hamner.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013
Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings
Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving
Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.